Home Search Abstracts View Session E-mail Abstract Author


Session 76 Poster Abstracts
Neurocognitive Dysfunction: Immunologic Mechanisms, Biomarkers, and CNS Drug Penetration
Session Day and Time: Monday, 1 - 4 pm
Poster Hall


386    
Central Nervous Cytokine Patterns in Different Stages of HIV Infection
Thorsten Nolting*1, E Koutsilieri2, I W Husstedt3, N Gregor3, M Maschke4, M Obermann4, P Riederer2, S Sopper5, V ter Meulen2, G Arendt1, and Competence Network HIV/AIDS
1Univ Hosp of Duesseldorf, Germany; 2Univ of Wuerzburg, Germany; 3Univ Hosp of Muenster, Germany; 4Univ Hosp of Duisburg-Essen, Germany; and 5German Primate Ctr, Goettingen

Background:  It is well known that cytokine patterns in the central nervous system (CNS) of HIV-infected individuals differ from those of the uninfected population. But it is unknown whether a rather inflammatory or anti-inflammtory, pro-apoptotic or anti-apoptotic cytokine environment is present in different stages of the HIV-infection. The same is true for the influence of HAART on cytokine patterns.

Methods:  We included in the present study, 33 HIV+, neurologically asymptomatic individuals, divided into non-AIDS and AIDS patients and subdivided according to whether they were on HAART. Their data were compared with those of 5 HIV healthy controls. Cytokine levels in cerebrospinal fluid (CSF) were detected with an antibody array.

Results:  In non-AIDS patients without HAART, there is a significant up-regulation of the inflammatory cytokines:  interleukin (IL) -6, IL-12, IL-18, monocyte chemoattractant protein 1 (MCP-1), matrix metalloprotease (MMP) -2, MMP-3, MMP-9, tumor necrosis factor-alpha (TNF-α), and the apoptosis-inducing receptor TRAIL R1. The anti-inflammatory cytokines, eg, IL-10, remain at normal levels. This inflammation is in part reduced by HAART, but recurs in treated AIDS patients, even when HAART is actually successful and there is no history of drug failure. We find no clear correlation of cytokine patterns with viral load, CSF routine parameters, and neuropsychological deficits in those patients but a significant (eg, p = 0.009, TNF-α) correlation with duration of HIV-positivity.

Conclusions:  HIV-1 provokes a long-lasting inflammatory reaction in the CSF. This inflammation can be reduced by HAART in non-AIDS patients. In ongoing disease, the inflammatory CSF reaction in AIDS patients relapses independently from HAART. This may be one explanation for the absence of positive influence of HAART on neuropsychological impairment that is globally detected in the majority of neuroAIDS cohorts. Additionally, anti-inflammatory therapeutic interventions combined with an early start of HAART may be beneficial in HIV patients.